LINC00313 and cholangiocarcinoma: Similarly, blocking SMAD3 activation using SIS3 inhibitor completely abolished the TGFβ-mediated upregulation of LINC00313 and SERPINE1 in CCA cell lines (HuCCT1 and Huh28) (Fig. 2B).